The growing case for stainless steel versus single-use in mRNA vaccine production
Oct
4
2023
On demand

The growing case for stainless steel versus single-use in mRNA vaccine production

Wednesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Sponsor
The growing case for stainless steel versus single-use in mRNA vaccine production

Live30 webinars are thirty-minute presentations designed toupdate you on the latest innovations, applications, and data in a fast yetinteractive format.

As mRNA vaccine production matures into a post-pandemic world, and timelines stretch out, the industry will need to consider whether stainless steel manufacturing equipment provides a better solution than the single-use equipment currently dominating the landscape. As supply chains settle, the price volatility and limited availability of stainless steel are less of a concern, and in many cases, stainless steel may offer a significantly better overall return on investment (ROI).

  • Pros and cons of single-use vs stainless steel in mRNA vaccine production
  • Case studies of straightforward tech transfer into stainless steel unit operations
  • Insight into the pricing and lead times of stainless steel equipment currently
  • Example ROI calculations demonstrating net benefit to manufacturing companies
Steve Attig
Steve Attig
Fellow – Bioprocess Design at CRB

Steve Attig is a Fellow, Bioprocess Design, with more than 25 years of experience in process engineering, project management and operations. He focuses on and biotechnology applications. His broad and deep experience allows for rapid execution of pre-feasibility studies for startups, and mid- and large-scale pharma clients looking for early cost and facility design implications.

SPEAKERS

Steve Attig
Steve Attig
Fellow – Bioprocess Design at CRB

You might also like

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Emily Neil, Ariadna Pascual
27 June
in 60
Days
Register
Precision in production: optimizing monitoring and quality control for high-value plasmids

Precision in production: optimizing monitoring and quality control for high-value plasmids

Oleksandr Karpenko
6 June
in 39
Days
Register
Advancing cell therapy: innovations in polymer-based encapsulation and delivery

Advancing cell therapy: innovations in polymer-based encapsulation and delivery

Y Brudno, O Veiseh, M Delic-Schlumbohm et al.
5 June
in 38
Days
Register
Pure and simple: understanding LNP analytics for better mRNA-based drugs

Pure and simple: understanding LNP analytics for better mRNA-based drugs

Adam Crowe
29 May
in 31
Days
Register
Empowering patient care: in-process and quality control solutions for cellular therapies

Empowering patient care: in-process and quality control solutions for cellular therapies

Christin Tischner, Simon Lennartz
23 May
in 25
Days
Register